322-Washington,America - 23
Emergency Call- 24/7 support
Home » Food and Beverages » Food Additives » FFO-7060817
* For discount/customization and buying a particular chapter click here or write to us at firstname.lastname@example.org
Global beta glucan market refers to the market of sugar which is extracted from bacteria, fungus, yeast, cereal algae. Beta glucans are used for boosting immune system in the person whose body defenses have weaken due to conditions such as stress, chronic fatigue, physical or mental stress and others. Beta glucan has huge growth opportunity in cosmetics and medicine sector as beta glucan has its application in skin health promotions focusing in antioxidant activity, anti-wrinkle activity, wound healing, and skin permeation absorption moisturizing and other. Beta glucan has wide growth opportunity in the cosmetics industry due to its health and skin benefits. Thus, rise in cosmetic industry is expected to fuel the adoption of beta glucan in cosmetic products and widen the growth opportunity of the market in cosmetics. The companies are continuously looking for development of new and innovative products to capture market potentail available for beta glucan in cosmetic sector. For instance, Ceapro Inc. (Canada) launched its cosmeceutical products JUVENTE, a new anti-aging skin care product with the active ingredients of beta glucan in Oct, 2017. Similarly, Jordan based BioNAtural company offer beta Glucan (oat powder) as an anti-aging agent and also as a restructuring replenish agent.
Growing health concern among consumers is expected to be a major factor that is boosting market growth. There are various researches across the globe that states the advantages offered by beta glucan in improving the strength and immunity of the human body. For instance, a study conducted by the US Department of Agriculture’s Beltsville Human Nutrition Research Center found that beta glucan significantly lowers the cholesterol level of men and women those have high cholesterol. In addition, a study conducted by Japanese researchers at Tokyo University Biotechnology Research Center found that “lentinan”, a type of beta glucan, has anti-tumor properties and is used for increasing the lifespan of patients suffering from breast, stomach and colorectal cancer. Furthermore, beta glucan has been widely used for escalating the immunity of the body in various circumstances such as stress, chronic fatigue, physical or mental stress, etc. In addition, it helps in maintaining the energy levels of patients undergoing radiation treatment and chemotherapies. Moreover, beta glucan is also adopted by the clinicians and physicians for treating serious diseases including AIDS, tumors and others. Immune system of the patients affected by HIV AIDS is boosted by beta glucan and it is also used in the treatment of cancer. Thus, high adoption of beta glucan due to rise in health concern is boosting growth in global beta glucan market. Moreover, various side effects of consuming beta glucan and inconsistency in regulatory norms are the major factor that are restricting the growth of market.
Source: OBRC Analysis.
Global beta glucan market is segmented on the basis of source and end-user. The market report scope is widely characterized based on category of beta glucan that include soluble and insoluble beta glucan. The total market revenue is restricted to revenues generated from net adoption of beta glucan across various end-user vertical and revenues of end-user products that contain beta glucan as an ingredient has been excluded from the report scope.
By source, global beta glucan market is further segmented into:
By end user, global beta glucan market is further segmented into:
By category, global beta glucan market is further segmented into:
In category segment, soluble beta glucan segment accounts to largest market share in terms of revenue. The largest share of market is mainly attributed by high adoption of cereal derived beta glucan as a dietary substitute to lower risk associated with heart diseases. Furthermore, pharmaceuticals end user dominates end user segment during forecast period. The growth in pharmaceutical end user is majorly contributed by rising use of beta glucan to treat diseases such as cancer, AIDS, etc. Beta glucans can mobilize cancer fighting cells, specifically natural killer cells that play a vital role to inhibit the cancer growth. Thus, the high prevalence of diseases such as cancer, diabetes is expected to boost growth of beta glucan in pharmaceutical. Moreover, by sources segment, cereals segment is expected to experience highest CAGR during forecast period. The growth in cereals segment is driven by rise in adoption of cereal based beta glucan in food and beverages industry. Oats rich beta glucan are extensively used as fat substitute in ready-to-eat oat breakfast foods and snacks to meet the increasing demand for healthy processed food.
Global beta glucan market has divided into four region that includes;
Geographically, Europe is the leading market region for global beta glucan market in terms of market revenue share. The dominance of Europe is attributed towards the fact of presence of majority of the key players. The key players include Pharmacon ASA (Norway), Tate & Lyle PLC (UK), Ohly (Germany), DSM N.V. (Netherlands) and others. Further, the increasing regulatory approvals of beta glucan across Europe is also driving the Europe beta glucan market. For instance, in April 2016, an application related to authorization of beta-glucans was accepted by FSAI (Food Safety Authority of Ireland) that was submitted by Leiber GmbH (Germany), as per Food Safety Authority of Ireland. Further, as per a research paper published by AACC International (2017), the countries cross Europe such as UK, Netherlands, Spain and Italy witnessed high dietary fiber consumption. Netherlands witnessed the top position all over the world in consuming dietary fibers in terms of grams/day. Hence, pertaining the above facts, OBRC analysis finds Europe as the second most favorable region for investment over the forecast period (2017-2024). However, North America is expected to emerge as the fastest growing region during the forecast period 2017-2024. Factors such as presence of major key players and initiatives taken by them is promoting growth in North America beta glucan market.
Major market players of the global Beta glucan market are:
Market players are adopting numerous strategies such as partnership, collaboration, product launch and merger & acquisition to sustain in the dynamic market. Whereas, product launch is amongst the key strategy adopted by the companies in the global Beta glucan market.
For Example; In August 2015, Ohly (Germany) announced the launch of "Auxoferm". This product is Saccharomyces boulardii based. that is a probiotic yeast inclined towards transforming efficacy of the oral rehydration systems used by patients across the globe.
In 2015, Wellmune from Biothera Inc., was acquired by Kerry Group Plc (Israel). Wellmune is a supplement ingredient and natural food and beverages that helps to strengthen the immune system and it was a clinically proven. This acquisition is expected to result in increase in geographical presence and market share of the company.
The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis.
Key reason to buy the report:
How we are different from others:
At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape, with giving extensive SCOT analysis of key companies.
Key findings of the global Beta glucan market